|

STK-012 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Synthekine1

Indications

  • 1st Line NSCLC1
  • Untreated Advanced NSCLC1
  • Advanced Solid Tumor1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Tucson, Arizona1 trial

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

University of Arizona Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.